Key result
Myocardial preconditioning cuts serum creatinine ~43% and limits kidney apoptosis following ischemia-reperfusion in rats.
Why the study?
Acute kidney injury is a common and serious complication of cardiac surgery with unclear underlying mechanisms and no specific preventative or therapeutic options.
Does myocardial preconditioning reduce kidney injury and apoptosis induced by myocardial ischaemia and reperfusion in a rat model?
Does myocardial preconditioning reduce kidney injury and apoptosis induced by myocardial ischaemia and reperfusion in a rat model?
Absolute Event Rate: 0.65% vs 1.15%
p-value: p=<0.05
Myocardial preconditioning reduces kidney injury and apoptosis induced by myocardial ischaemia and reperfusion in a rat model, potentially via inhibition of TNF-α and modulation of apoptotic pathways.
Myocardial preconditioning attenuated remote renal injury in rats; leaves open clinical translation to human myocardial ischemia-reperfusion.
OBJECTIVES: Acute kidney injury is a common and serious complication of cardiac surgery. Because its underlying mechanisms are unclear, there is no specific therapy to prevent or treat it. A regional transient ischaemia and reperfusion (I/R) may provide protection to distant tissue or organs, a phenomenon known as remote preconditioning. In this study, we investigated whether myocardial preconditioning (MPC) would reduce kidney injury and apoptosis induced by myocardial I/R, as well as the mechanisms involved. METHODS: Myocardial I/R was induced by a 40-min occlusion of the left anterior descending artery and a 3-h reperfusion in anaesthetized Sprague-Dawley rats. MPC was elicited by two 10-min coronary artery occlusions and two 10-min reperfusions. A sham group received the same surgical procedures without coronary artery occlusion and reperfusion. RESULTS: Compared with the sham group, myocardial I/R significantly increased the serum creatinine levels (1.15 ± 0.44 vs 0.54 ± 0.23 mg/dl, P < 0.05, mean ± standard deviation) and renal histological damage, indicating increased kidney injury. Kidney apoptosis was also significantly increased, as evidenced by the increase in the terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate (dUTP) nick-end labelling (TUNEL)-positive nuclei, clear DNA laddering and increased caspase-3 activation. Serum levels of tumour necrosis factor-α (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6) were significantly elevated, as were TNF-α levels in the kidneys. MPC significantly decreased myocardial infarct size (18.5 ± 3.1 vs 25.6 ± 2.1% of area at risk, P < 0.001). Additionally, MPC significantly reduced the serum creatinine level (0.65 ± 0.19 mg/dl, P < 0.05), renal histological damage and apoptosis. The increase in the serum levels of TNF-α, IL-1 and IL-6, and of TNF-α in the kidneys, was significantly inhibited. Western blot analysis found that MPC significantly increased Bcl-2 and decreased Bax in the kidneys. Phosphorylation of Akt and extracellular signal-regulated kinases 1 and 2 (ERK1/2) was significantly increased. Haemodynamics, area at risk and mortality did not differ significantly among the groups. CONCLUSIONS: MPC significantly reduces kidney injury and apoptosis induced by myocardial I/R. The underlying mechanisms might be related to inhibition of both the extrinsic and intrinsic pathways of apoptosis, possibly via inhibition of TNF-α production, modulation of Bcl-2 and Bax and activation of Akt and ERK1/2.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2014) studied Myocardial ischaemia and reperfusion. Myocardial preconditioning vs. Myocardial ischaemia and reperfusion without preconditioning was evaluated on Serum creatinine levels (p=<0.05). Myocardial preconditioning significantly reduced serum creatinine levels (0.65 vs 1.15 mg/dl, P<0.05) and kidney apoptosis induced by myocardial ischaemia and reperfusion in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: